Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Eric Mark Horwitz, MD

LICENSE # 0101275855
 
Issue Date: 7/5/2022
Expiration Date: 9/30/2024
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 9/13/2022
Temple University School Of Medicine - Philadelphia PA
Rank: Full Professor
Years: 2013

Academic Appointments - Non-US
Last Updated 9/13/2022
None Reported
Publications
(up to ten in the last five years)
Last Updated 9/13/2022
The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy
Eur Urol
Volume: 79
Date: 04 2021
pubmed.ncbi.nlm.nih.gov/33390282/

A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients
Int J Radiat Oncol Phys
Volume: 110
Date: 07 2021
pubmed.ncbi.nlm.nih.gov/33539968/

Comparison of Multimodal Therapies and Outcomes Among Patients with High-Risk Prostate Cancer with Adverse Clinicopathologic Features.
JAMA Netw Open
Volume: 4
Date: 07 2021
pubmed.ncbi.nlm.nih.gov/34196715/

Adverse events reported by patients with cancer after administration of a 2-dose mRNA covid-19 vaccine.
J Natl Compr Canc Netw
Volume: 20
Date: 01 2022
pubmed.ncbi.nlm.nih.gov/35130494/

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions.
J Urol
Volume: 208
Date: 01 2022
pubmed.ncbi.nlm.nih.gov/35536141/

Early PSA kinetics for low- and intermediate-risk prostate cancer treated with definitive radiation therapy
Pract Radiat Oncol
Volume: 12
Date: 01 2022
pubmed.ncbi.nlm.nih.gov/34303033/

Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy with or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts
JAMA Oncol
Volume: 31
Date: 03 2022
pubmed.ncbi.nlm.nih.gov/35050303/

Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/0526)
Int J Radiat Biol Phys
Volume: 112
Date: 04 2022
pubmed.ncbi.nlm.nih.gov/34740768/

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management
J Urol
Volume: 208
Date: 05 2022
https://pubmed.ncbi.nlm.nih.gov/35536144/

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up
J Urol
Volume: 208
Date: 05 2022
pubmed.ncbi.nlm.nih.gov/35536148/